When cells’ tiny differences have far-reaching implications
Alex Shalek’s technologies for single-cell RNA profiling can help dissect the cellular bases of complex diseases around the globe.
Alex Shalek’s technologies for single-cell RNA profiling can help dissect the cellular bases of complex diseases around the globe.
The targeted approach eliminated tumors in mice, with minimal side effects.
The potent new adjuvant could be used to help make vaccines against HIV and other infectious diseases.
Boosting the efficiency of single-cell RNA-sequencing helps reveal subtle differences between healthy and dysfunctional cells.
With computer models and lab experiments, researchers are working on a strategy for vaccines that could protect against any influenza virus.
In lab tests, virus-like DNA structures coated with viral proteins provoke a strong immune response in human B cells.
Study finds specific cells in the lungs, nasal passages, and intestines that are more susceptible to infection.
Researchers apply network theory to HIV protein structure, uncovering a vital link between connectivity and protective immune response.
Ragon Institute researchers develop a method to identify weak points in viral proteins that could be exploited for vaccine development.
Enlisted in the fight against HIV, MIT engineers and scientists contribute new technology, materials and computational studies.
New technology could help AIDS researchers develop new vaccines.
Vaccines that target newly identified viral protein sequences could be more effective than previous efforts.
A new finding from the Ragon Institute of MGH, MIT and Harvard may have implications for designing an effective AIDS vaccine.
Partial success of a new AIDS vaccine offers clues to help develop a stronger vaccine, say MIT’s Arup Chakraborty and MGH’s Bruce Walker.